5-Lipoxygenase Inhibitors [MoA] - N0000175955

Pharmacologic Class Information

Pharmacologic Code N0000175955
Pharmacologic Name 5-Lipoxygenase Inhibitors
Pharmacologic Uses
  • 5-lipoxygenase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with 5-Lipoxygenase Inhibitors

The table contains 5 products whose active ingredient are classified under the same pharmacologic class 5-Lipoxygenase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
10122-901Zyflo Non-Proprietary Name: ZileutonTabletOralChiesi Usa, Inc.ACTIVE
31722-044Zileuton Non-Proprietary Name: ZileutonTablet, Film Coated, Extended ReleaseOralCamber Pharmaceuticals, Inc.ACTIVE
51407-741Zileuton Non-Proprietary Name: ZileutonTablet, Multilayer, Extended ReleaseOralGolden State Medical Supply, Inc.ACTIVE
64380-189Zileuton Non-Proprietary Name: ZileutonTablet, Multilayer, Extended ReleaseOralStrides Pharma Science LimitedACTIVE
64980-206Zileuton Non-Proprietary Name: ZileutonTablet, Extended ReleaseOralRising Pharmaceuticals, Inc.ACTIVE